doi:10.1111/iju.12609International Journal of Urology
dose-escalating phase ii study of thalidomide for the treatment of patients with low-risk myelodysplastic syndromes the thal-smd-2000 trial of the groupe fran ccedil;ais des my eacute;lodysplasies.pdf 2017-01-17上传 dose-escalating phase ii study of thalidomide for the treatment of patients with...
Lebret T, Gaudez F, Herve´ JM, Barre´ P, Lugagne PM, Botto H. Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success. Eur Urol 1998;34:67-72.Lebret T, Gaudez F, Herve´ JM, et al. Low-dose BCG instilla- ...
eacuteric DebiegraveveARTHRITIS & RHEUMATISMTamirou F, Husson SN, Gruson D, et al. Brief report: the Euro-Lupus low-dose intravenous cyclophosphamide regimen does not impact the ovarian reserve, as measured by serum levels of anti-mullerian hormone. Arthritis Rheumatol 2017;69:1267-71....
M. MiftenY. VinogradskiyV. MoiseenkoJ. GrimmE. YorkeA. JacksonW.A. TomeacuteR. Ten HakenN. OhriRadiotherapy and OncologyMiften M, Vinogradskiy Y, Moiseenko V: Radiation Dose-Volume Effects for Liver SBRT. Radiother Oncol. 2016;119(1):1....
Here we present a recent controlled experiment examining the effect of various force application variables (hammer shape; location of force application; angle of blow; hammer displacement speed) on flake morphology. Results indicate that the independent variables interact with flake attributes in a ...
Glerant J, Martinez P, Guillaume C, Jounieaux V. Comparison of 2 maintenances doses (100 microg vs 200 microg) in Hymenop- tera venom immunotherapy: influence of the maintenance dose on the immunologic response. Ann Allergy Asthma Immunol. 2005;94:451-6....
Robles Peacuterez-Monteoliva, NRCarrasco Martin, JLQuijano MartiacuteJournal of HypertensionHIGH-RISKH YPE RTENSIVE PATIENTS:ASSESSMENT OF BLOOD PRESSURE CONTROL,ADHERENCE TO FIXED-DOSE COMBINATION TREATMENTSANDSA TISF ACTION. M.A.Prieto Diaz,J.A.Divison Garrote,J.Abellan Aleman,et al. Journal...
Honore PM, Joannes-Boyau O, Collin V, Boer W, Jennes S (2009) Continuous hemofiltration in 2009: what is new for clinicians regarding pathophysiology, preferred technique and recommended dose? Blood Purif 28:135–143HONORE, P. M., JOANNES-BOYAU, O., COLLIN, V., BOER, W. & JENNES, ...
mycophenolate mofetilmycophenolic acidtherapeutic drug monitoringTo date, neither the benefit of mycophenolic acid (MPA) therapeutic drug monitoring (TDM), the prodrug of mycophenolate mofetil (MMF), nor the optimal monitoring technique have been established in autoimmune diseases. This study was ...